Updated June 9, 2021
Important and useful resources as the COVID-19 vaccines are distributed to the health care teams and the public. More content will be added as it becomes available.
Janssen (Ad26.COV2.S) Vaccine:
April 13: The FDA and CDC has recommended that use of the Johnson & Johnson COVID-19 vaccine be paused after reports of blood clots in patients receiving the vaccine.
- Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine
- Janssen COVID-19 Vaccine EUA Letter of Authorization
- Janssen COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers
- Janssen COVID-19 EUA Fact Sheet for Recipients and Caregivers
- Vaccines and Related Biological Products Advisory Committee February 26, 2021 Meeting Briefing Document - FDA
- Vaccines and Related Biological Products Advisory Committee February 26, 2021 Meeting Briefing Document - Janssen
Moderna (MRNA-1273) Vaccine:
- Moderna COVID-19 Vaccine EUA Letter of Authorization:
- Moderna COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers
- Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers
- Moderna Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Briefing Document - FDA
- Moderna Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Briefing Document- Moderna
Pfizer (BNT162b2 ) Vaccine:
- Pfizer-BioNTech COVID-19 Vaccine EUA Letter of Authorization
- Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers
- Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Patients
- Pfizer Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Briefing Document- FDA
- Pfizer Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Briefing Document- Pfizer
From the CDC
- COVID-19 Vaccination
- V-safe
- COVID-19 Vaccination Toolkits
- COVID-19 ACIP Vaccine Recommendations
- CDC Health Advisory Network release: Cases of Cerebral Venous Sinus Thrombosis with Thrombocytopenia after Receipt of the Johnson & Johnson COVID-19 Vaccine
- Joint Media Call: FDA & CDC to Discuss Janssen COVID-19 Vaccine
From CMS
From ACEP
- Poster and Flyer for Vaccine Hesitant Populations
- Smart Phrases about COVID-19 Vaccines in Multiple Languages
- Key Points About the Johnson & Johnson (Janssen) Vaccine Update
- Where Can Individual Emergency Physicians Get Vaccinated for Protection Against COVID-19?
- ACEP Chapter and Spokesperson COVID-19 Vaccine Public Education Toolkit
- ACEP Statement on Emergency Physicians’ Priority Access to the COVID-19 Vaccine
- ACEP: What Emergency Physicians Need to Know About the COVID-19 Vaccine
- ACEP Toolkit for COVID-19 Emergency Department (ED) Vaccination Programs
From ASHP
- COVID-19 Vaccine (Janssen) - Information for Patients
- COVID-19 Vaccine (Janssen) - Information for Patients - Spanish
- COVID-19 Vaccine (Moderna) - Information for Patients
- COVID-19 Vaccine (Moderna) - Information for Patients - Spanish
- COVID-19 Vaccine (Pfizer-BioNTech) - Information for Patients
- COVID-19 Vaccine (Pfizer-BioNTech) - Information for Patients - Spanish
Other Resources
